Relief Therapeutics Holding AG Capital Reinvestment Ratio
Relief Therapeutics Holding AG capital reinvestment ratio. Relief Therapeutics Holding AG (RLF) has a Capital Reinvestment Ratio of 0.04x as of December 2024, meaning it reinvests 0% of its operating cash flow (CHF359.00K) in capital expenditures (CHF14.00K). Check Relief Therapeutics Holding AG cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Relief Therapeutics Holding AG (2006–2006)
Capital reinvestment ratio of Relief Therapeutics Holding AG from 2006 to 2006. This chart tracks Relief Therapeutics Holding AG's Capital Reinvestment Ratio across 1 annual periods. Also explore net asset momentum of Relief Therapeutics Holding AG to track the company's year-over-year net asset growth rate.
Relief Therapeutics Holding AG Capital Reinvestment Ratio by Year (2006–2006)
Relief Therapeutics Holding AG capital reinvestment ratio by year from 2006 to 2006. For the full cash flow conversion analysis, see Relief Therapeutics Holding AG operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2006 | 0.21x | CHF2.28 Million | CHF474.60K | — |